ARCHIVES

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

This article is from The Cancer Letter archive.

Vol. 18 No. 41 | October 23, 1992

Download PDF Visit The Full Archive

Related Articles

Leter: Payers Must Determine Appropriate Therapies

July 19, 1996

New NCI Division Wins Approval To Fund Grants In Basic Biobehavioral Research

April 17, 1998

Cancer Letter Editor Finalist for Loeb Award

May 16, 2003

FDA Proposes New Nonclinical Lab Regs

November 26, 1976

Clinical Education Grants Held To 170 Payline, No New Awards; Organ Site Renewals Limited To 180

March 26, 1982

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

October 7, 1994